Ibuprofen Oral Suspension: Medication for Relieving Pain and Fever

Overview:

Ibuprofen is an FDA (Food and Drug Administration) approved non-steroidal anti-inflammatory drug (NSAID) that originates from propionic acid and is notably one of the initial propionics. Researchers first explored its development in 1960 as a safer alternative to Aspirin. Ibuprofen received its patent in 1961 and was introduced to combat rheumatoid arthritis in the UK (United Kingdom) in 1969 and in the USA (United States of America) in 1974. It marked the first over-the-counter NSAID available to the public.

Studies have concluded that Ibuprofen is equally safe and as effective as Acetaminophen in treating pain and fever in both adult and pediatric populations.

For Patients:

What Is Pain and Fever?

Fever and pain are common ailments that affect individuals. They are not dangerous for health; they are simply signals sent by the body to indicate that something is amiss. Fever is a natural defense mechanism that helps the body fight viral and bacterial infections.

What Is Ibuprofen Oral Suspension?

Ibuprofen oral suspension is classified under non-steroidal anti-inflammatory drugs (NSAIDs). Ibuprofen is administered to children to alleviate mild to moderate muscular pain, headaches, earaches, sore throats, dental pain, and backaches. Additionally, it can be used for minor injuries like sprains and strains. It effectively reduces fever, including post-immunization fever, and alleviates other symptoms associated with colds and influenza.

How Should the Patient Take Ibuprofen Oral Suspension?

This product should be stored at room temperature and shielded from light and moisture. Make sure it is out of reach of children and pets, and do not store it in the bathroom. Do not flush expired or no longer needed medications down the toilet or pour them into drains unless instructed to do so.

What Are the Things to Inform the Doctor Before Taking Ibuprofen Oral Suspension?

Before using Ibuprofen oral suspension, it is crucial to consider and communicate the following:

• Any previous asthma attacks, hives, or allergic reactions to Aspirin or other NSAID (Non-steroidal anti-inflammatory drugs) medications.

• Any recent or upcoming heart bypass surgery, as with NSAID medications, should not be taken immediately before or after such procedures.

In addition to this, patients should inform their physician about:

• All of their medical conditions ensure the safe use of Ibuprofen oral suspension.

• All the medicines they are currently taking. Some medications, when combined with NSAIDs, can lead to serious side effects. Maintaining a list of medications to share with the healthcare provider and pharmacist is advisable.

• Pregnancy, as NSAID medicines, should not be used during the later stages of pregnancy.

• Discuss with the doctor to assess the safety of using Ibuprofen oral suspension while nursing.

What Are the Side Effects of Oral Suspension from Ibuprofen?

Serious side effects associated with Ibuprofen oral suspension encompass:

• Heart attack.

• Stroke.

• High blood pressure.

• Heart failure resulting from body swelling (fluid retention).

• Kidney problems, including kidney failure.

• Bleeding, as well as stomach and intestinal ulcers.

• Low red blood cells (anemia).

• Life-threatening skin and allergic reactions.

• Liver problems, including liver failure.

• Asthma attacks in individuals with pre-existing asthma.

Other, less severe side effects may include:

• Stomach pain.

• Constipation.

• Diarrhea.

• Gas.

• Heartburn.

• Nausea.

• Vomiting.

• Dizziness.

For Doctors:

Indication and Usage:

Ibuprofen oral suspension is a pharmaceutical agent indicated for a range of therapeutic purposes. Understanding its specific indications and proper use is essential for healthcare providers:

• Relief of Muscular Pain: Ibuprofen oral suspension is advised for the treatment of mild to moderate muscular pain.

• Post-Immunization Pyrexia: It can be administered to alleviate pyrexia (fever) following immunization.

• Symptomatic Relief: Ibuprofen oral suspension is effective in providing symptomatic relief from various conditions, including headache, earache, dental pain, and backache.

• Minor Injuries: It may be employed for the management of minor injuries, like sprains and strains.

• Feverishness: Ibuprofen oral suspension is indicated to relieve feverishness.

• Colds and Influenza: It can be employed to alleviate symptoms associated with colds and influenza.

• Dysmenorrhea: Ibuprofen oral suspension is an option for managing dysmenorrhea (painful menstruation).

• Neuralgia: It is suitable for relieving neuralgia, characterized by nerve pain.

• Post-Operative Pain: For the treatment of post-operative pain, oral suspension of Ibuprofen can be considered.

• Rheumatoid Arthritis: Ibuprofen oral suspension is effective in managing rheumatoid arthritis, including juvenile rheumatoid arthritis or Still's disease.

• Ankylosing Spondylitis: It is a therapeutic option for patients with ankylosing spondylitis.

• Osteoarthritis: Ibuprofen oral suspension can be prescribed for the management of osteoarthritis.

• Non-Rheumatoid Arthropathies: It is indicated for the treatment of other non-rheumatoid (seronegative) arthropathies.

• Periarticular Conditions: Ibuprofen oral suspension can be employed for periarticular conditions like frozen shoulder (capsulitis), bursitis, tendonitis, tenosynovitis, and low back pain.

• Soft Tissue Injuries: It is suitable for use in soft tissue injuries like sprains and strains.

Dosage and Administration:

Dosage and usage guidelines for Ibuprofen oral suspension are discussed below.

1. Adults, Elderly, and Children Over 12 Years: The lowest effective dose should be used for the shortest duration to manage symptoms in adults, the elderly, and children over 12 years of age. In case of persistent or worsening symptoms or if the medication is taken for more than ten days, seek medical advice.

Recommended Dose: 200 mg to 400 mg (10 to 20 ml), up to three times a day as needed.

• Maintain a minimum of four hours between doses.

• Do not exceed 1200 mg (60 ml) within a 24-hour period.

2. Children: 20 mg/kg/day divided into doses for pain and fever (including over-the-counter use).

• Infants Between the Ages of Three and Six Months (Weighing More Than Five Kilograms): Take one 2.5 ml dose three times within 24 hours. It is recommended not to use this medicine for more than 24 hours.

• Infants Six Months to One Year: 2.5 ml three to four times a day.

• Children One to Four Years: Five ml three times a day.

• Children Four to Seven Years: 7.5 ml three times a day.

• Children Seven to 12 Years: 10 ml three times a day.

3. Post-Immunization Fever: Start with 2.5 ml (12.5 mg), then give another 2.5 ml (12.5 mg) six hours later if necessary.

• Do not exceed two doses in 24 hours.

• Consult a doctor if the fever is not reduced.

4. Juvenile Rheumatoid Arthritis (Prescription Only Use): Three or four divided doses of 30 to 40 mg/kg/day (milligrams per kilogram per day)may be taken.

5. Elderly: Dosage modifications are not necessary unless renal or hepatic function is impaired. Dosage should be assessed individually in such cases.

Clinical Pharmacology

1. Mechanism of Action and Pharmacodynamics: Ibuprofen, as a racemic mixture consisting of [-]R- and [+]S-isomers, primarily derives its clinical activity from the [+]S-isomer. The [-]R-form, considered pharmacologically inactive, undergoes gradual and incomplete (~60 percent) conversion into the active [+]S species among adults. Although the degree of interconversion in children remains uncertain, it is believed to be similar. The [-]R-isomer acts as a circulating reservoir to sustain active drug levels. Ibuprofen is well-absorbed orally, with less than one [percent excreted unchanged in urine. It displays a biphasic elimination pattern characterized by a plasma half-life of approximately two hours. Dose-proportionality has been established for Ibuprofen in both febrile children (five and 10 mg/kg doses) and adults (single oral doses ranging from 50 to 600 mg for the total drug and up to 1200 mg for the free drug).

2. Pharmacokinetics: Ibuprofen is well-absorbed orally, with less than one percent excreted unchanged in urine. It exhibits biphasic elimination, with a plasma half-life of around two hours. Febrile children and adults show dose-proportional responses, indicating predictability in dosing.

• Absorption: Ibuprofen exhibits substantial oral absorption from the suspension formulation, with peak plasma levels typically reached within one to two hours.

• Antacids: An investigation in adults has confirmed that Ibuprofen's absorption remains unaffected when co-administered with antacids containing aluminum hydroxide and magnesium hydroxide.

• H-2 Antagonists: Human volunteer studies have shown that co-administration of Cimetidine or Ranitidine with Ibuprofen does not exert a significant impact on Ibuprofen serum concentrations.

• Food Effects: The rate of absorption is highest when Ibuprofen is administered under fasting conditions. When taken with food, the time to peak concentration (Tmax) is delayed by roughly 30 to 60 minutes, and peak levels experience an approximately 30 to 50 percent reduction.

• Distribution: Ibuprofen, typical of most drugs in its class, exhibits high protein binding (>99 percent) that becomes saturable at concentrations >20 mcg/mL (micrograms per milliliter). Binding is non-linear at these higher concentrations. While oral dosing data suggest an age- or fever-related shift in the volume of distribution for ibuprofen, the clinical significance of this finding remains unclear. Febrile children under 11 years of age exhibit a volume of approximately 0.2 L/kg (liters per kilogram), whereas adults have a volume of 0.12 L/kg (approximately).

• Metabolism: Following oral administration, a majority of the dose is recovered within 24 hours in the urine, primarily in the form of hydroxy-(25 percent) and carboxypropyl-(37 percent) phenylpropionic acid metabolites. Urine analysis indicates that approximately one percent of Ibuprofen is free, while 14 percent is conjugated. The remaining drug and its metabolites are found in stool.

• Elimination: Ibuprofen undergoes rapid metabolism and urinary elimination, typically reaching complete excretion 24 hours after the last dose. It displays a biphasic plasma elimination profile with a half-life of about 2.0 hours. While no difference in observed terminal elimination rate or half-life exists between children and adults, there is an age- or fever-related change in total clearance, suggesting alterations in ibuprofen's volume of distribution.

Usage In Specific Populations:

1. Pregnancy

• Teratogenic Effects: No evidence of abnormal development has been found in reproductive studies performed on rats and rabbits. Nevertheless, human reaction is not always predicted by research on animal reproduction. Pregnant women have not been the subject of sufficient, carefully monitored studies. Ibuprofen should only be used during pregnancy if the possible advantages outweigh the possible risks to the developing fetus.

• Nonteratogenic Effects: Pregnancy-related use of non-steroidal anti-inflammatory drugs, especially in late pregnancy, should be avoided due to their known effects on the fetal cardiovascular system (closure of ductus arteriosus).

2. Labor and Delivery: NSAIDs have been shown to increase the incidence of dystocia, delay parturition, and reduce pup survival in rat studies. These effects are similar to those of other medications that are known to inhibit prostaglandin synthesis.It is unknown how Ibuprofen Suspension affects labor and delivery in expectant mothers. As a result, giving Ibuprofen Suspension during labor and delivery is not advised.

3. Nursing Mothers: The drug's ability to be eliminated in human milk is unknown. Given that many medications are excreted in human milk and that Ibuprofen suspension can cause serious adverse reactions in nursing infants, a decision should be made regarding whether to stop nursing or to stop taking the medication, taking the mother's need for the medication into consideration.

4. Pediatric Usage: The effectiveness and safety of Ibuprofen suspension in pediatric patients below the age of six months have not been established. Dosing of Ibuprofen suspension in children six months or older should be guided by their body weight.

5. Geriatric Use: As with any NSAIDs, caution should be taken in managing the elderly (those ages 65 years and older).

What Are the Contraindications of Ibuprofen Oral Suspension?

The contraindications are listed below.

• Ibuprofen suspension must not be administered to individuals with a confirmed hypersensitivity to Ibuprofen.

• Patients who have previously exhibited asthma, urticaria, or allergic-type responses following the ingestion of Aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) should not be given Ibuprofen suspension. Severe, though exceptionally rare, anaphylactic-like reactions to NSAIDs have been documented in such cases.

• Ibuprofen suspension is not recommended for managing perioperative pain during CABG surgery (coronary artery bypass graft surgery).

What Are the Adverse Effects of Ibuprofen Oral Suspension?

In patients taking Ibuprofen or other NSAIDs, the most commonly reported adverse experiences occurring in approximately one to ten percent of patients include:

• Abnormal renal function.

• Anemia.

• Dizziness.

• Edema.

• Elevated liver enzymes.

• Fluid retention.

• Gastrointestinal issues (including abdominal pain, bloating, constipation, diarrhea, dyspepsia, epigastric pain, flatulence, heartburn, nausea, vomiting).

• Headaches.

• Increased bleeding time.

• Nervousness.

• Pruritus.

• Rashes (including maculopapular).

• Tinnitus.

Additional adverse experiences that are reported occasionally encompass various body systems:

• Body as a Whole: Fever, infection, and sepsis.

• Cardiovascular System: Congestive heart failure in individuals who have impaired cardiac function, hypertension, tachycardia, and syncope.

• Digestive System: The digestive system includes conditions like dry mouth, esophagitis, gastritis, hematemesis, hepatitis, jaundice, melena, and rectal bleeding.

• Hemic and Lymphatic System: Thrombocytopenia, eosinophilia, leukopenia, purpura, stomatitis, ecchymosis.

• Nutrition and Metabolic: Variations in weight.

• Nervous system: Symptoms include asthenia, anxiety, disorientation, depression, irregular dreams, lethargy, insomnia, malaise, paresthesia, somnolence, tremors, and vertigo.

• Respiratory System: Asthma and dyspnea.

• Skin and Appendages: Alopecia, photosensitivity, and perspiration.

• Special Senses: Blurry vision.

• Urogenital System: Cystitis, dysuria, hematuria, oliguria/polyuria, proteinuria, and acute renal failure in patients whose kidney function was severely impaired before the urogenital system was introduced.

Warnings and Precautions:

Warnings:

• Cardiovascular Risks: Clinical trials spanning up to three years involving various COX-2 (cyclooxygenase) selective and nonselective NSAIDs have revealed an elevated risk of severe cardiovascular (CV) thrombotic events, myocardial infarction, and potentially fatal strokes. When treating patients with NSAIDs, use the lowest effective dose for the shortest amount of time to reduce this risk. Physicians and patients must remain vigilant for CV event symptoms, even without prior CV issues.

• Hypertension: NSAIDs, including Ibuprofen suspension, can precipitate hypertension, especially in those already at risk. Patients using thiazides or loop diuretics may experience reduced responsiveness when taking NSAIDs, requiring BP (blood pressure) monitoring during NSAID therapy.

• Gastrointestinal Effects: NSAIDs, including Ibuprofen suspension, carry a risk of serious gastrointestinal (GI) adverse events, such as inflammation, bleeding, ulceration, and perforation. This risk increases with prolonged use. Caution is advised in patients with prior ulcer disease or GI bleeding risk factors.

• Renal Effects: Long-term NSAID use has been associated with renal injuries. Patients at highest risk include those with impaired renal function, heart failure, liver dysfunction, diuretic and ACE (angiotensin-converting enzyme) inhibitor use, and the elderly. Monitor renal function during NSAID therapy.

• Advanced Renal Disease: Ibuprofen suspension is not recommended in patients with advanced renal disease. Monitor renal function if therapy is necessary.

• Anaphylactoid Reactions: Anaphylactoid reactions can happen in patients without prior NSAID exposure. Patients with the Aspirin triad should not use Ibuprofen suspension.

• Skin Reactions: NSAIDs, including Ibuprofen suspension, can cause severe skin adverse events. When a skin rash or hypersensitivity appears, stop immediately.

• Pregnancy: Avoid Ibuprofen during late pregnancy.

Precautions:

• General: Ibuprofen suspension should not replace corticosteroids. Gradually taper corticosteroid therapy discontinuation.

• Hepatic Effects: Up to 15 percent of patients may experience mild liver test elevations with NSAIDs, including Ibuprofen suspension. Severe liver reactions are rare but can occur. Evaluate for liver issues if symptoms develop.

What Are the Drug Interactions of Ibuprofen Oral Suspension?

The drug interactions of Ibuprofen oral suspension are discussed below.

• ACE Inhibitors: There are reports indicating that NSAIDs may potentially reduce the antihypertensive effectiveness of ACE inhibitors. It is advisable to consider this interaction when patients are concurrently taking NSAIDs and ACE inhibitors.

• Aspirin: As is the case with other NSAIDs, it is generally not recommended to administer Ibuprofen alongside Aspirin due to the potential for increased adverse effects.

• Diuretics: Both clinical studies and post-marketing observations have revealed that Ibuprofen can attenuate the natriuretic impact of Furosemide and Thiazides in certain patients. This outcome has been linked to the inhibition of renal prostaglandin synthesis. When NSAIDs are given concurrently, it is essential to closely monitor patients for signs of renal impairment and to ensure diuretic effectiveness.

• Lithium: In a study involving 11 normal volunteers, Ibuprofen led to elevated plasma lithium levels and reduced renal lithium clearance. The mean minimum lithium concentration increased by 15 percent, and renal lithium clearance decreased by 19 percent during concurrent drug administration. This effect is attributed to Ibuprofen's inhibition of renal prostaglandin synthesis. Therefore, when Ibuprofen and lithium are used together, close monitoring for signs of lithium toxicity is imperative.

• Methotrexate: Reports suggest that NSAIDs may competitively inhibit Methotrexate accumulation in rabbit kidney slices. This indicates the potential to enhance Methotrexate's toxicity. Caution should be exercised when administering NSAIDs concurrently with Methotrexate.

• Warfarin: Numerous short-term controlled studies have failed to demonstrate a significant impact of Ibuprofen tablets on prothrombin times or various other clotting factors in individuals receiving Warfarin-type anticoagulants. However, given reports of bleeding associated with the use of Ibuprofen tablets and other NSAIDs in patients on Warfarin-type anticoagulants, physicians should exercise caution when prescribing Ibuprofen tablets to such patients. The combined effects of Warfarin and NSAIDs on GI bleeding are synergistic, increasing the risk of serious GI bleeding when both drugs are used together compared to either drug used alone.

Overdose and Toxicity:

The severity of an Ibuprofen overdose depends on the quantity of the drug ingested and the time elapsed since ingestion. Individual reactions may vary, necessitating a case-by-case evaluation. Although infrequent, serious toxicity and fatalities have been documented in medical reports involving Ibuprofen overdoses.

Common symptoms of an Ibuprofen overdose include:

• Abdominal pain.

• Nausea.

• Vomiting.

• Lethargy.

• Drowsiness.

Additional central nervous system symptoms may encompass:

• Headache.

• Tinnitus.

• CNS depression.

• Seizures.

Rarely, an overdose may lead to metabolic acidosis, coma, acute renal failure, and apnea, particularly in very young children. Cardiovascular toxicity, including atrial fibrillation, tachycardia, and hypotension, has also been reported.

Clinical Studies:

In clinical trials with children aged six months to 12 years suffering from viral fever, Ibuprofen oral suspension (five and 10 mg/kg) was compared to Acetaminophen Elixir (10 to 15 mg/kg). Results showed that both Ibuprofen doses and Acetaminophen were equally effective in reducing fever within the first hour. The most significant fever reduction occurred between two and four hours. However, when baseline temperatures were above 102.5 degrees Fahrenheit, the 10 mg/kg Ibuprofen dose was more effective. The group given Ibuprofen at a dose of five mg/kg had a tendency to have a fever recurrence after six hours, whereas the group given a dose of 10 mg/kg still showed a significant reduction in fever at eight hours. In the control group treated with 10 mg/kg of Acetaminophen, the pattern of fever reduction resembled that seen in the five mg/kg Ibuprofen group, except that temperature elevation tended to return one to two hours earlier.